Owens & Minor Sells Medical Distribution to Cardinal Health for $1B

TL;DR

O&M selling medical distribution to Cardinal Health for $1B cash, closing H1 2025.

AI Summary

Owens & Minor, Inc. announced on October 11, 2024, that it has entered into a definitive agreement to sell its Medical Distribution business to an affiliate of Cardinal Health, Inc. for approximately $1.0 billion in cash. This strategic divestiture is expected to close in the first half of 2025, subject to customary closing conditions.

Why It Matters

This significant divestiture allows Owens & Minor to focus on its higher-growth Medical Solutions segment and improve its financial flexibility. For Cardinal Health, it represents a substantial expansion of its distribution network.

Risk Assessment

Risk Level: medium — The transaction is subject to customary closing conditions and regulatory approvals, introducing potential delays or complications.

Key Numbers

• $1.0B — Sale Price (Cash proceeds from the sale of the Medical Distribution business to Cardinal Health.)

Key Players & Entities

• Owens & Minor, Inc. (company) — Seller
• Cardinal Health, Inc. (company) — Buyer
• $1.0 billion (dollar_amount) — Sale price
• October 11, 2024 (date) — Announcement date
• first half of 2025 (date) — Expected closing period

FAQ

Key Financial Figures

• $2 — nge on which registered Common Stock, $2 par value per share OMI New York St

Filing Documents

• d896571d8k.htm (8-K) — 29KB
• 0001193125-24-237188.txt ( ) — 146KB
• omi-20241011.xsd (EX-101.SCH) — 3KB
• omi-20241011_lab.xml (EX-101.LAB) — 17KB
• omi-20241011_pre.xml (EX-101.PRE) — 11KB
• d896571d8k_htm.xml (XML) — 3KB

Forward Looking Statements

Forward Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding our expectations regarding the proposed Merger and the future performance and financial results of the Company's business and other non-historical statements. Some of these statements can be identified by terms and phrases such as "outlook," "believes," "expects," "potential," "continues," "may," "will," "should," "could," "seeks," "predicts," "intends," "trends," "plans," "estimates," "anticipates" or the negative version of these words or other comparable words. The Company cautions readers of this communication that such "forward looking statements," wherever they occur in this communication or in other statements attributable to the Company, are necessarily estimates reflecting the judgment of the Company's senior management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the "forward-looking statements." Factors that could cause the Company's actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to: the occurrence of any event, change or other circumstances that could give rise to the termination of the Merger Agreement; the inability to complete the proposed Merger due to the failure to obtain approval of Rotech's stockholders for the proposed Merger or the failure to satisfy other conditions to completion of the proposed Merger, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the proposed Merger; risks related to disruption of management's attention from the Company's ongoing business operations due to the proposed Merger; the effect of the announcement of the proposed Merger on the Company's relationships

View Full Filing

View this 8-K filing on SEC EDGAR